Skip to content

Presentation by Virally Infected Cells of Antigenic Proteins Utilized in Natural Killer Cell Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) 2256335

Jul 2026 · Journal of Immunology · Vol 215 · 0 citations

TL;DR

The data indicate that antibodies to the S protein alone are unlikely to support ADCC to coronavirally infected cells, and that depletion of anti-S from antisera from infected persons had negligible effect on ADCC.

Abstract

The presence of viral proteins in the plasma membranes of infected cells is essential for natural killer (NK) cell antibody-dependent cell-mediated cytotoxicity (ADCC). However, many enveloped viruses assemble inside cells rather than budding out through plasma membranes. Thus, the presence of viral proteins in plasma membranes of infected cells is uncertain, as is which of several viral structural proteins participates in ADCC. Their presence might represent leftover proteins after virion assembly. To address external viral protein display and its sufficiency for antibody-dependent recognition, we utilized the endemic, cold-causing human coronavirus OC-43, a surrogate virus for SARS-CoV-2. We used NK-92-CD16A lymphocytes as killer cells, OC-43 from BEI, and infected, 51Cr-radiolabeled lung A549 cells as ADCC ‘targets’. Viral proteins were monitored by immunofluorescent microscopy. Antibodies to OC-43 included two monoclonal anti-spike S with human Fc’s, plasma from children who had OC-43 respiratory infections, rabbit affinity purified polyclonal anti-nucleocapsid N and S, and sera from unimmunized rabbits. We found that all the antibody reagents reacted with OC-43 infected cells by immunofluorescent microscopy. Labeling of external viral proteins was punctate. However, only the immune plasma and the non-immunized rabbit sera supported ADCC. The finding with anti-S was surprising since the human mAb 1249A8 anti-S could support Fc-receptor dependent phagocytosis of beads with S protein [PMID35862475]. The finding is consistent with PMID35587364, that SARS CoV-2 S was under-expressed in plasma membranes of infected cells and that depletion of anti-S from antisera from infected persons had negligible effect on ADCC. The finding with anti-N was surprising in light of PMID41060789. Conclusions are premature but the data indicate that antibodies to the S protein alone are unlikely to support ADCC to coronavirally infected cells. University of Nevada, Reno Foundation Award. Viral Immunology (VIR)

View source

Similar papers

Jul 2026

Measurement of the Reduction of OC-43 Coronavirus Production by Natural Killer Cell Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) 2260991

While substantial viral production before day 3 is observed, ADCC on day 3 reduced the subsequent production by over 75% and the data indicate that early ADCC will substantially reduce the spread of coronaviral infections.

Kendra Cook, J. C. Amaya, Nandini Naidu et al. · 0 citations
Open access Jul 2026

Plasmacytoid dendritic cell discrete subpopulations with contrasting functions are elicited by CD4+ T cells infected or not by HIV-1 or HIV-2 2260395

It is found thatasmacytoid dendritic cells cross-present antigens from HIV-1-infected CD4+ T cells to specific cytotoxic T cells to specific cytotoxic T cells during chronic infection.

A. Hosmalin, Daniela Apostol, S. Isnard et al. · 0 citations
Open access Jul 2026

Viral modulation of antigen presentation: influenza A viral protein PA-X disrupts MHC I during infection 2334714

Through regulation of MHC I gene expression, PA-X decreases the rate of MHC I trafficking during infection, allowing the virus to replicate and spread, particularly in hosts with prior immunity to influenza A virus, and contributing to the continued success of this virus.

Alessandra C. Setaro, M. Gaglia · 0 citations
Open access Aug 2026

Expression of the C-type lectin receptor CD205 on B cells mediates HIV-1 binding and trans infection of CD4+ T cells

CD205 is identified as a critical receptor on B cells that facilitates HIV-1 binding and the transfer of virus to CD4+ T cells, and these findings may inform strategies for limiting the viral reservoir in people living with HIV.

A. Gerberick, Allison E. DePuyt, Peter E. J. Shoucair et al. · 0 citations
Open access Aug 2026

Oncolytic HSV1716 attenuates tumor-killing activity of infected primary NK cells

It is demonstrated that primary human NK cells are infected by HSV1716 and undergo functional and phenotypic changes, leading to a diminished cytotoxic capacity.

K. Susek, D. Holla, C. Marsal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.